Cargando…

Resolution of a chronic viral infection after interleukin-10 receptor blockade

A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this pape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejrnaes, Mette, Filippi, Christophe M., Martinic, Marianne M., Ling, Eleanor M., Togher, Lisa M., Crotty, Shane, von Herrath, Matthias G.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118120/ https://www.ncbi.nlm.nih.gov/pubmed/17030951 http://dx.doi.org/10.1084/jem.20061462

Ejemplares similares

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

A Novel Technique for the In Vivo Imaging of Autoimmune Diabetes Development in the Pancreas by Two-Photon Microscopy
por: Coppieters, Ken, et al.
Publicado: (2010)

Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells
por: Baca Jones, Carmen, et al.
Publicado: (2014)

Transforming Growth Factor-β Suppresses the Activation of CD8(+) T-Cells When Naïve but Promotes Their Survival and Function Once Antigen Experienced : A Two-Faced Impact on Autoimmunity
por: Filippi, Christophe M., et al.
Publicado: (2008)

Immunosuppressive Mechanisms During Viral Infectious Diseases
por: Sarikonda, Ghanashyam, et al.
Publicado: (2010)

T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
por: Juedes, Amy E., et al.
Publicado: (2004)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

Potential viral pathogenic mechanism in human type 1 diabetes
por: Schneider, Darius A., et al.
Publicado: (2014)

Increased Memory Conversion of Naïve CD8 T Cells Activated during Late Phases of Acute Virus Infection Due to Decreased Cumulative Antigen Exposure
por: Fousteri, Georgia, et al.
Publicado: (2011)

OX40 Facilitates Control of a Persistent Virus Infection
por: Boettler, Tobias, et al.
Publicado: (2012)

Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
por: Rivas, J.R., et al.
Publicado: (2021)

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
por: Sullivan, Kevin M, et al.
Publicado: (2023)

Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis
por: Castellano, Lucio Roberto, et al.
Publicado: (2015)

Trading off fiscal budget adherence and child protection
por: Cavalca, Petra Gram, et al.
Publicado: (2022)

Interleukin-1 Receptor Blockade in Perinatal Brain Injury
por: Rosenzweig, Jason M., et al.
Publicado: (2014)

Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice
por: Christen, Selina, et al.
Publicado: (2013)

Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model
por: Coppieters, Ken T., et al.
Publicado: (2013)

Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
por: Sutherland, Andrew P.R., et al.
Publicado: (2009)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Expression of Interleukin-8, Interleukin-10 and Epstein-Barr Viral-Load as Prognostic Indicator in Nasopharyngeal Carcinoma
por: Savitri, Eka, et al.
Publicado: (2015)

Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade
por: Christersdottir, Tinna, et al.
Publicado: (2019)

Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ
por: Fousteri, G., et al.
Publicado: (2010)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies
por: Burrer, Renaud, et al.
Publicado: (2007)

Why not treat human cancer with interleukin-1 blockade?
por: Dinarello, Charles A.
Publicado: (2010)

Preemptive interleukin-6 blockade in patients with COVID-19
por: Guillén, Lucía, et al.
Publicado: (2020)

Rethinking interleukin-6 blockade for treatment of COVID-19
por: Scherger, S., et al.
Publicado: (2020)

Interleukin‐1 blockade treatment decreasing cardiovascular risk
por: Zheng, Zi‐Heng, et al.
Publicado: (2019)

Effects of interleukin‐6 receptor blockade on allergen‐induced airway responses in mild asthmatics
por: Revez, Joana A, et al.
Publicado: (2019)

Is Interleukin-6 blockade a viable strategy to prevent progression of acute respiratory distress syndrome in non-COVID viral pneumonia?
por: Padappayil, Rana Prathap, et al.
Publicado: (2023)

Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity
por: Guerau-de-Arellano, Mireia, et al.
Publicado: (2009)

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
por: von Herrath, Matthias G., et al.
Publicado: (2005)

Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()
por: Coppieters, Ken T., et al.
Publicado: (2014)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Interleukin 1 blockade withcanakinumab for Hyper IGD syndrome (HIDS)
por: Brunnner, J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_149qa1f4d4ajnhqin29qfav3ss